Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Jun 21, 2021

SELL
$59.34 - $66.74 $3.53 Million - $3.97 Million
-59,447 Closed
0 $0
Q4 2020

Mar 09, 2021

SELL
$57.74 - $65.43 $216,698 - $245,558
-3,753 Reduced 5.94%
59,447 $3.69 Million
Q3 2020

Dec 14, 2020

SELL
$57.43 - $63.64 $128,413 - $142,299
-2,236 Reduced 3.42%
63,200 $3.81 Million
Q2 2020

Aug 03, 2020

SELL
$54.82 - $64.09 $9,593 - $11,215
-175 Reduced 0.27%
65,436 $3.85 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $113,030 - $164,259
-2,436 Reduced 3.58%
65,611 $3.66 Million
Q4 2019

Jan 16, 2020

BUY
$49.21 - $64.19 $32,478 - $42,365
660 Added 0.98%
68,047 $4.37 Million
Q3 2019

Oct 23, 2019

BUY
$42.77 - $50.71 $13,429 - $15,922
314 Added 0.47%
67,387 $3.42 Million
Q2 2019

Aug 06, 2019

BUY
$44.62 - $49.34 $2.99 Million - $3.31 Million
67,073 New
67,073 $3.04 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tealwood Asset Management Inc Portfolio

Follow Tealwood Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tealwood Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tealwood Asset Management Inc with notifications on news.